A blood test can predict the risk of dementia in women up to 25 years before symptoms appear, researchers say.Experts in the US found that higher levels of a protein called p-tau217 – which is linked ...

Researchers say elevated p-tau217 levels in older women were strongly linked to future dementia, raising hopes for earlier detection and prevention strategies.

A simple test can forecast dementia risk in women as much as 25 years ahead of symptoms emerging, it has been found. Scientists says the findings could help change the way people are treated before ...

A comprehensive study encompassing more than 160,000 dementia patients has revealed something alarming. The medication risperidone has been linked to an elevated stroke risk across all groups of ...

The blood biomarker p-tau217 has "shown the most promise in detecting Alzheimer's in the brain," researchers of a new study say.

Researchers from the University of California San Diego have found that a novel blood-based biomarker can predict a woman's risk of developing dementia as many as 25 years before symptoms appear.

A massive UK study of more than 165,000 dementia patients has uncovered troubling new evidence about risperidone, a commonly ...

Delirium: Often mistaken for dementia, acute confusion may result from infections, medications or metabolic imbalances and always should be investigated. Eyesight and hearing impairments: Sensory ...

A singing circle at Amsterdam’s Concertgebouw helps people with dementia and other brain conditions connect through music.

The $40 million Agrace Dementia Village, to be built on the hospital's 6-acre campus, will instead offer a true village, one ...

Women with higher levels of p-tau217, a blood protein, were twice as likely to eventually develop dementia or mild cognitive impairment.